With respect to cutaneous carcinomas, targeting LC-specific molecules such as Langerin may be the key to generating the desired tumor-specific CD8+ T cell response with the induction of high-avidity CTL clones [27, 30, 32]. The gene discussed is CD207; the disease is neoplasm.